◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 7743

SEED Co.,Ltd. (7743) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Instruments & Supplies · DATA UPDATED 2026-08-12

SEED Co.,Ltd. (7743) operates in the Medical Instruments & Supplies industry and is headquartered in Tokyo, Japan with about 1,048 employees. Its market capitalization is roughly JPY 16 billion. In the fiscal year ended 2026-03-31, 7743 reported JPY 33.9B in revenue and JPY 1.1B in net income.

SEED Co.,Ltd. manufactures and sells contact lenses and care products in Japan.

Interactive charts & full statements →

7743 Revenue & Earnings History — Annual Income Statement

Income statement2026-03-312025-03-312024-03-312023-03-312022-03-31
Total RevenueJPY 33.9BJPY 33.2BJPY 32.4BJPY 30.6B
Gross ProfitJPY 15.2BJPY 14.6BJPY 14.2BJPY 11.6B
Operating Income (EBIT)JPY 1.4BJPY 1.6BJPY 2.1BJPY 630M
Net IncomeJPY 1.1BJPY 1.1BJPY 2.0B(JPY 316M)

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

7743 Free Cash Flow History

Cash flow2026-03-312025-03-312024-03-312023-03-312022-03-31
Dividends Paid(JPY 454M)(JPY 454M)(JPY 300M)(JPY 300M)

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

7743 Balance Sheet History

Balance sheet2026-03-312025-03-312024-03-312023-03-31
Total AssetsJPY 62.5BJPY 51.8BJPY 49.6BJPY 40.0B
Total LiabilitiesJPY 42.9BJPY 33.4BJPY 31.9BJPY 27.9B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 7743 viewer.

Other Companies in Medical Instruments & Supplies

← 7741All “0-9” companies7744 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.